Sustained allogeneic kidney graft operational tolerance despite discontinued conventional immunosuppression after CD19-CAR-T cell therapy for relapsed/refractory posttransplant lymphoproliferative disorder

Hansmann H, Henkel C, Fante MA, Harrer DC, Heidemanns S, Oellerich M, Beck J, Schutz E, Biswenger V, Perl M, Zartner B, Edinger M, Wolff D, Hoffmann P, Herr W, Banas B, Zecher D, Hansmann L. Sustained allogeneic kidney graft operational tolerance despite discontinued conventional immunosuppression after CD19-CAR-T cell therapy for relapsed/refractory posttransplant lymphoproliferative disorder. Am J Transplant. 2025 Sep 17. doi:10.1016/j.ajt.2025.09.009. PMID: 40972901